Corrigendum to ‘Phosphorylated Rasal2 facilitates breast cancer progression’

• Xuan Wang,
• Christopher Qian,
• Yinlong Yang,
• Meng-Yue Liu,
• Ya Ke,
• Zhong-Ming Qian

Affiliations

Xuan Wang

Institute of Translational & Precision Medicine, Nantong University, 19 Qi Xiu Road, Nantong, JS 226019, China; Department of Pharmacology and Biochemistry, Fudan University School of Pharmacy, 826 Zhangheng Road, Pu Dong, Shanghai 201203, China

Christopher Qian

School of Biomedical Sciences and Gerald Choa Neuroscience Centre, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, NT, Hong Kong

Yinlong Yang

Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai 200000, China

Meng-Yue Liu

Institute of Translational & Precision Medicine, Nantong University, 19 Qi Xiu Road, Nantong, JS 226019, China

Ya Ke

School of Biomedical Sciences and Gerald Choa Neuroscience Centre, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, NT, Hong Kong; Corresponding authors.

Zhong-Ming Qian

Institute of Translational & Precision Medicine, Nantong University, 19 Qi Xiu Road, Nantong, JS 226019, China; Department of Pharmacology and Biochemistry, Fudan University School of Pharmacy, 826 Zhangheng Road, Pu Dong, Shanghai 201203, China; Corresponding authors.